VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
PRLB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
PRLBProto Labs, Inc.
$89.13$2.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. PRLB
  4. Financial Ratios

Proto Labs, Inc. (PRLB) Financial Ratios

Latest Ratios: P/E Ratio 101.3x · EV/EBITDA 33.6x · ROE 3.2%. (2009–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

PRLB Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$2.1B$1.2B$986M$1.0B$700M$1.4B$4.1B$2.7B$3.1B$2.8B$1.4B
Enterprise Value$2.0B$1.1B$900M$943M$665M$1.4B$4.0B$2.6B$3.0B$2.7B$1.3B
P/E Ratio →101.2857.4959.2359.03—42.4481.1643.2140.1453.3731.89
P/S Ratio3.982.301.972.031.432.919.505.996.908.034.58
P/B Ratio3.221.831.471.471.001.716.404.695.686.003.59
P/FCF35.5520.5614.3522.6217.3267.5168.8151.0485.8856.3032.99
P/OCF28.4616.4612.6613.9411.2725.7038.5723.6725.0333.8218.20

P/E links to full P/E history page with 30-year chart

PRLB EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—2.101.801.871.362.799.235.746.717.934.35
EV / EBITDA33.5718.6714.6814.3110.0119.9343.4023.7925.8730.1416.34
EV / EBIT76.8936.0736.1832.47—33.8863.7332.4432.6436.7220.17
EV / FCF—18.7813.1120.8916.4564.7366.9148.9383.5155.6531.32

PRLB Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin44.5%44.5%44.6%44.1%44.1%45.6%50.1%51.3%53.6%56.3%56.0%
Operating Margin4.9%4.9%5.1%5.6%5.5%5.7%13.8%17.4%20.0%21.0%20.7%
Net Profit Margin4.0%4.0%3.3%3.4%-21.2%6.8%11.7%13.9%17.2%15.0%14.3%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE3.2%3.2%2.4%2.5%-13.6%4.5%8.3%11.3%15.3%12.3%12.1%
ROA2.8%2.8%2.2%2.2%-12.0%4.0%7.2%9.8%13.5%11.1%11.0%
ROIC3.4%3.4%3.2%3.3%2.8%3.2%9.0%12.9%15.1%14.6%15.7%
ROCE3.8%3.8%3.6%3.9%3.4%3.6%9.1%13.4%17.1%16.7%17.0%

PRLB Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.010.010.010.010.030.010.020.02—0.01—
Debt / EBITDA0.080.080.060.080.320.110.140.11—0.06—
Net Debt / Equity—-0.16-0.13-0.11-0.05-0.07-0.18-0.19-0.16-0.07-0.18
Net Debt / EBITDA-1.77-1.77-1.40-1.19-0.53-0.86-1.24-1.02-0.74-0.35-0.87
Debt / FCF—-1.78-1.25-1.73-0.87-2.78-1.91-2.11-2.37-0.65-1.66
Interest Coverage——124.3626.41———————

Net cash position: cash ($111M) exceeds total debt ($5M)

PRLB Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio3.493.493.664.042.613.344.824.974.083.896.74
Quick Ratio3.273.273.433.762.423.104.604.763.893.636.34
Cash Ratio1.911.911.942.071.121.413.223.382.502.224.62
Asset Turnover—0.700.670.650.610.530.580.680.720.670.72
Inventory Turnover20.5520.5522.5720.6420.1020.1719.9422.1820.5113.3714.08
Days Sales Outstanding—55.7550.5854.3859.9960.8549.0845.7153.1756.5142.26

PRLB Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield1.0%1.7%1.7%1.7%—2.4%1.2%2.3%2.5%1.9%3.1%
FCF Yield2.8%4.9%7.0%4.4%5.8%1.5%1.5%2.0%1.2%1.8%3.0%
Buyback Yield2.0%3.5%6.1%4.3%4.2%1.6%0.4%1.2%0.4%0.2%0.0%
Total Shareholder Yield2.0%3.5%6.1%4.3%4.2%1.6%0.4%1.2%0.4%0.2%0.0%
Shares Outstanding—$24M$25M$26M$27M$28M$27M$27M$27M$27M$27M

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetFortress
Cash FlowStable
Top Statement Risk

Network segment margin dilution

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Margin Expansion Signals Mix Shift

Gross margin expanded to 46.4% in 2026Q2 from 44.3% a year earlier, as reported in financial statements, suggesting a favorable mix shift toward higher-margin in-house services and improved pricing power.

The 210 basis point year-over-year gross margin improvement, coupled with operating margin nearly doubling to 7.6%, indicates that the company is finally realizing operating leverage after years of heavy investment in its digital platform. However, the persistence of a ~38 percentage point gap between gross and operating margins suggests that SG&A and R&D costs remain structurally high, likely reflecting the ongoing need to maintain the proprietary software and sales infrastructure. Investors should monitor whether this margin expansion is durable or a one-quarter effect driven by project mix.

ROIC Inflection Points to Efficiency Gains

ROIC improved to 1.5% in 2026Q2 from 0.8% a year earlier, based on reported figures, suggesting that the company is beginning to generate better returns on its invested capital after a period of stagnation.

The doubling of ROIC from 0.7% in 2025Q2 to 1.5% in 2026Q2, while still low in absolute terms, indicates that the asset base is becoming more productive. This improvement is driven primarily by margin expansion rather than asset turnover, which has remained flat at 0.19x. The low ROIC relative to the cost of capital suggests that the company is still in the early stages of monetizing its heavy investments in manufacturing capacity and software, and investors should watch whether this trend can be sustained as revenue growth continues.

Working Capital Cycle Lengthens Slightly

The cash conversion cycle extended to 50 days in 2026Q2 from 49 days a year earlier, as per financial statements, reflecting a modest increase in days sales outstanding to 56 days.

The slight lengthening of the CCC, driven by DSO increasing from 52 to 56 days year-over-year, suggests that the company may be extending payment terms to larger customers as part of its strategic pivot toward bigger accounts. DIO and DPO have remained stable, indicating that inventory management and supplier relationships are not the primary drivers of working capital changes. The increase in DSO, while small, warrants monitoring as it could signal a shift in customer mix toward larger, slower-paying enterprises, which may have implications for cash flow timing.

Debt-Free Balance Sheet Preserves Optionality

Proto Labs maintains a near-zero debt profile with a D/E ratio of 0.00 and D/EBITDA of 0.12 in 2026Q2, according to recent filings, providing a fortress-like balance sheet that minimizes refinancing risk.

The company's minimal debt, down from $5.0M in 2024Q1 to $2.2M in 2026Q2, underscores a conservative capital structure that allows management to weather cyclical downturns and invest in growth initiatives without the burden of interest expense. Interest coverage is effectively infinite given the negligible debt, but the low D/EBITDA ratio suggests that even if the company were to lever up, it would have substantial capacity. This financial flexibility is particularly valuable given the cyclicality of the prototyping business and the ongoing strategic pivot toward larger customers.

Ample Liquidity Buffers Against Volatility

The current ratio improved to 3.64 in 2026Q2 from 3.60 a year earlier, with cash of $127.9M, as reported in the balance sheet, providing a strong buffer against working capital swings.

With a quick ratio of 3.43, the company's liquidity position is exceptionally strong, and it could cover its current liabilities more than three times over without relying on inventory sales. This ample liquidity is critical given the lumpy cash flow patterns observed in the prior cash flow analysis, where free cash flow swung from $30.4M to $9.2M quarter-over-quarter. The fortress-like balance sheet, combined with near-zero debt, suggests that Proto Labs is well-positioned to fund its strategic initiatives and withstand potential demand shocks without external financing.

P/E Misleads on Growth Potential

The trailing P/E of 91.19 appears extreme, but forward P/E of 39.69, based on reported figures, suggests the market is pricing in significant earnings growth, making the metric less meaningful for this asset-heavy digital manufacturer.

The most commonly misapplied ratio for Proto Labs is the trailing P/E, which is distorted by the company's historically low earnings base and significant stock-based compensation. A more appropriate valuation metric is EV/EBITDA, which at 30.05x still appears rich but better captures the company's cash-generating ability and its capital structure. Additionally, investors should consider the price-to-sales ratio of 3.58x, which, when compared to the company's accelerating revenue growth, may indicate that the market is pricing in a sustained recovery in profitability. The wide gap between trailing and forward earnings multiples highlights the market's expectation of a sharp earnings inflection, which is not yet fully reflected in historical ratios.

Download Financial Ratios Data

Includes 30+ ratios · 17 years · Updated daily

Consensus & Technical Research Suite
Open PRLB Terminal

PRLB Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PRLB — Frequently Asked Questions

Quick answers to the most common questions about buying PRLB stock.

What is Proto Labs, Inc.'s P/E ratio?

Proto Labs, Inc.'s current P/E ratio is 101.3x. The historical average is 49.1x. This places it at the 100th percentile of its historical range.

What is Proto Labs, Inc.'s EV/EBITDA?

Proto Labs, Inc.'s current EV/EBITDA is 33.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 22.4x.

What is Proto Labs, Inc.'s ROE?

Proto Labs, Inc.'s return on equity (ROE) is 3.2%. The historical average is 31.6%.

Is PRLB stock overvalued?

Based on historical data, Proto Labs, Inc. is trading at a P/E of 101.3x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are Proto Labs, Inc.'s profit margins?

Proto Labs, Inc. has 44.5% gross margin and 4.9% operating margin.

How much debt does Proto Labs, Inc. have?

Proto Labs, Inc.'s Debt/EBITDA ratio is 0.1x, indicating low leverage. A ratio below 2x is generally considered financially healthy.